Task: Answer the MCQ question.
Question: Which compound exhibits a 17.443% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a) Cn1c(=O)n(C)c2cc(S(=O)(=O)Nc3cc(Cl)ccc3O)ccc21
b) O=C(Nc1ccccc1-c1nc2ccccc2s1)c1cccnc1
c) Cc1nc(SCC(=O)NC(=O)NC(C)C)nc(C)c1C
Answer: c. Cc1nc(SCC(=O)NC(=O)NC(C)C)nc(C)c1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nc(SCC(=O)NC(=O)NC(C)C)nc(C)c1C
Cc1nc(SCC(=O)NC(=O)NC(C)C)nc(C)c1C
N-(propan-2-ylcarbamoyl)-2-(4,5,6-trimethylpyrimidin-2-yl)sulfanylacetamide